BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination is a research paper published in JCI Insight (2020). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the American Diabetes Association
Grant: 1-19-PDF-117
National Institutes of Health grant
Grant: 1R01CA251698-01
Opposing Functions of BRD4 Isoforms in Breast Cancer
CPRIT
Grant: RP180349,RP190077
Welch Foundation
Grant: I-1805
Arnold O. Beckman Research Award
Grant: RB18061
National Institutes of Health R01 grants
Grant: DK062777,DK095842
NLM NIH HHS
Grant: HHSN276201200017C
NCI NIH HHS
Grant: R01 CA251698
NIDDK NIH HHS
Grant: R01 DK062777
NIDDK NIH HHS
Grant: R56 DK062777
NIDDK NIH HHS
Grant: R01 DK095842
National Institutes of Health
Grant: 5R01DK062777-07
Regulation of cholesterol catabolism by bile acids
National Institutes of Health
Grant: 5R01DK095842-04
Coordination of gut-liver bile acid signaling by FXR
FWCI
1.14
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals